EIF5A and infection: As the proof of principle in our studies, inhibitors targeting polyamine pathway (DFMO, clofazimine, ribavirin) and eIF5A hypusination (GC7) can be used as antivirals to block latent and lytic replications as well as de novo infection of KSHV (Fig 8).